By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Tempus 

600 West Chicago Avenue
Suite 775
Chicago  Ilinois  60654-2526  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS

Tempus is a technology company that has built an operating system to battle cancer. Tempus enables physicians to deliver personalized cancer care through its interactive analytical and machine learning platform. The company provides genomic sequencing services and analyzes molecular and therapeutic data to empower physicians to make real-time, data-driven decisions. Our goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as we gather more data.

YEAR FOUNDED:

2015

LEADERSHIP:

Co-Founder and CEO: Eric Lefkofsky

President: Dr. Kevin White

Chief Medical Informatics Officer: Dr. Jonathan Silverstein

COO: Ryan Fukushima

Director of Laboratory Operations: Sam Bettis

Scientific Adviser: Dr. Arul Chinnaiyan

CAREER:

Please click here for Tempus' job opportunities.


Key Statistics


Email: media@tempus.com
Ownership: Private

Web Site: Tempus
Employees:
Symbol: 
 



Industry
Diagnostics






Company News
Tempus And Northwestern Expand Partnership To Accelerate Personalized Medicine Efforts 5/12/2017 11:24:01 AM
Erik Phelps Joins Tempus As Executive Vice President And General Counsel 4/5/2017 12:53:23 PM
Tempus And University of Chicago Collaborate On Groundbreaking Breast Cancer Project 3/16/2017 8:08:55 AM
Tempus Teams With Major Academic Medical Center To Advance Treatment Options For Patients Diagnosed With Aggressive Brain Cancer 3/2/2017 7:41:54 AM
Tempus And University of Michigan Announce Pancreatic Cancer Collaboration 1/30/2017 8:08:08 AM
Tempus Release: Dr. Gary Palmer Joins Company As Chief Medical Officer 1/10/2017 6:28:03 AM
Tempus And Mayo Clinic Team Up To Personalize Care For Cancer Patients 1/4/2017 9:25:18 AM
Tempus Announces Collaboration With Abramson Cancer Center At Penn To Increase The Effectiveness Of Immunotherapy Treatment 11/30/2016 9:47:07 AM
//-->